This Article Full Text (PDF) eLetters: Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kataoka, S. Articles by Tsuruo, T. Search for Related Content PubMed PubMed Citation Articles by Kataoka, S. Articles by Tsuruo, T.

Apoptosis

Pharmaceutical Research Institute Kirin Brewery Co., Ltd., Tokyo, Japan Institute of Molecular and Cellular Bioscience University of Tokyo Tokyo, Japan

We have come to understand apoptosis as not merely a single form of cell death, but as a fundamental theme in cell biology that has far-reaching implications in the fields of physiology and pathology. At the present time, however, the mechanism of apoptosis is not clearly understood, as research into apoptosis is still at the initial stages. Nevertheless, the links between apoptosis and a variety of pathological conditions are gradually becoming clearer.

In this article, we will provide a simple explanation of apoptosis and its mechanism as a novel concept of cell death and discuss the way in which apoptosis has been linked to a variety of pathological conditions.

	WHAT IS APOPTOSIS?

Top What is Apoptosis? Mechanism of Apoptosis Apoptosis Abnormalities and... References

 

Apoptosis.

In normal tissue, cells that are no longer needed are rapidly eliminated without affecting the overall function of the tissue. In this process cells undergo an active and spontaneous suicide called programmed cell death. In fact, the majority of physiological cell deaths take the form of apoptosis. The word apoptosis is used, in contrast to necrosis, to describe the situation in which a cell actively pursues a course toward death upon receiving certain stimuli [1].

The morphological changes of apoptosis found in most cell types first involve contraction in cell volume and condensation of the nucleus. When this happens the intracellular organelles such as the mitochondria retain their normal morphology. As apoptosis proceeds, blebbing of the plasma membrane occurs, and the nucleus becomes fragmented. Finally, the cell itself fragments to form apoptotic bodies that are engulfed by nearby phagocytes. With respect to biochemical changes, it is known that the chromosomes become fragmented into nucleosome units, and DNA forms characteristic ladder patterns when subjected to agarose gel electrophoresis.

	MECHANISM OF APOPTOSIS

Top What is Apoptosis? Mechanism of Apoptosis Apoptosis Abnormalities and... References

 
It has been reported that apoptosis is induced in various cells by many kinds of irritations, but the precise mechanism is still unclear.

Cell injuries that induce apoptosis include those that cause DNA damage such as radiation and anticancer drugs, those that are mediated by the TNF receptor and Fas receptor (the so-called "death signal receptors"), and the deprivation of cytokines that supply survival signals such as IL-3 and erythropoietin.

The tumor suppressor gene p53 plays a very important role in apoptosis induced by damage to DNA. This has been demonstrated by studying resistance to apoptosis of cells derived from p53 knockout mice [2].

Other than the irritations that induce apoptosis, molecules that have been strongly implicated as major players in the drama of apoptosis include the Bcl-2 family proteins and the IL-1 converting enzyme (ICE) and its homolog proteases (caspase family). Both groups of proteins show homology with proteins that affect cell death in nematodes. It is believed that molecules that contribute to cell death have been well conserved in multicellular organisms all the way from the relatively primitive nematodes to mammals including humans.

It was discovered that Bcl-2 suppressed apoptosis induced in IL-3 dependent cells by deprivation of IL-3 [3]. It has since become the gene around which apoptosis research revolves.

Recently, it has become clear that cell death involving the Bcl-2 protein is under the control of similar proteins from the same family [4]. It is interesting that the phenomenon of cell death may be regulated by the balance of the molecules involved in it.

	APOPTOSIS ABNORMALITIES AND DISEASE

Top What is Apoptosis? Mechanism of Apoptosis Apoptosis Abnormalities and... References

 
Physiological cell death plays a major role in the growth and permanent maintenance of the human body [5]. In the process of forming the nervous system, neurons that do not form proper connections die. Physiological cell death also accompanies the removal of virus-infected cells by cytotoxic T cells, the elimination of autoreactive immune cells, the formation of the gut, the reconstitution of cartilage and bone, etc. When physiological cell death that normally should occur is inhibited, inappropriate physiological cell death may occur that is harmful to the body and forms the basis of disease. For example, in patients with neural degenerative disorders such as Alzheimer’s disease and Parkinson’s disease, we can find premature cell death in a particular subset of neurons. The death of T cells in AIDS patients is also a form of physiological cell death. Inhibition of cell death in the immune system enables the survival of autoreactive B cells and T cells, and is therefore a cause of autoimmune disorders.

Resistance to apoptosis and cancer malignancy.

Apoptosis has been particularly linked to cancer. Normal cells are programmed for death if they are subjected to many types of non-physiological stress such as anticancer drugs or radiation, if they become isolated from surrounding cells and are unable to receive their tissue-specific survival signals [6], or if oncogenes are expressed haphazardly [7].

On the other hand, it is believed that the ability to survive is enhanced in transformed cancer cells because they are more resistant to apoptosis, they exhibit resistance to anticancer drugs, they are no longer dependent on survival signals, and they can metastasize. Therefore, the cancer progresses as the cancer cells maintain the proliferative superiority they acquire from their oncogenes. In other words, when cancer cells become resistant to apoptosis, they become resistant to treatment, metastasize, and proliferate destructively. The concept that the malignancy of cancer is due to its resistance to apoptosis is a relatively new one and is worthy of further study.

	ACKNOWLEDGMENT

Top What is Apoptosis? Mechanism of Apoptosis Apoptosis Abnormalities and... References

	REFERENCES

Top What is Apoptosis? Mechanism of Apoptosis Apoptosis Abnormalities and... References

 

1. Kerr JFR, Harmon BV. Definition and incidence of apoptosis: an historical perspective. In: Tomei LD, Cope FO, eds. Apoptosis: the molecular basis of cell death, Vol. 3. New York: Cold Spring Harbor Laboratory Press, 1991:5-29.
2. Lowe SW, Schmitt EM, Smith SW et al. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993;362:847–849.[Medline]
3. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes hematopoietic cell survival and cooperates with c-myc to immortalize pre-B cell. Nature 1988;335:440–442.[Medline]
4. Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with BAX. Nature 1994;369:321–323.[Medline]
5. Barr PJ, Tomei LD. Apoptosis and its role in human disease. Bio/Technology 1994;12:487–493.[Medline]
6. Raff MC. Social controls on cell survival and cell death. Nature 1992;356:397–400.[Medline]
7. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogene. Nature 1992;359:554–556.[Medline]

This article has been cited by other articles:

				T. Sato, T. Machida, S. Takahashi, K. Murase, Y. Kawano, T. Hayashi, S. Iyama, K. Takada, K. Kuribayashi, Y. Sato, et al. Apoptosis Supercedes Necrosis in Mitochondrial DNA-Depleted Jurkat Cells by Cleavage of Receptor-Interacting Protein and Inhibition of Lysosomal Cathepsin J. Immunol., July 1, 2008; 181(1): 197 - 207. [Abstract] [Full Text] [PDF]

				B. Pertl and D. W. Bianchi Fetal DNA in Maternal Plasma: Emerging Clinical Applications Obstet. Gynecol., September 1, 2001; 98(3): 483 - 490. [Abstract] [Full Text] [PDF]

This Article Full Text (PDF) eLetters: Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kataoka, S. Articles by Tsuruo, T. Search for Related Content PubMed PubMed Citation Articles by Kataoka, S. Articles by Tsuruo, T.